KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on May 22, 2026 >>  ABB India 6688.85  [ 1.34% ]  ACC 1359.3  [ -0.09% ]  Ambuja Cements 436.35  [ -0.10% ]  Asian Paints 2638.95  [ 1.56% ]  Axis Bank 1285.25  [ 2.52% ]  Bajaj Auto 10546.8  [ -1.15% ]  Bank of Baroda 265  [ 0.74% ]  Bharti Airtel 1871.4  [ -0.73% ]  Bharat Heavy 408.55  [ 0.06% ]  Bharat Petroleum 295.55  [ -0.27% ]  Britannia Industries 5336.9  [ 0.09% ]  Cipla 1398.95  [ -0.19% ]  Coal India 456.45  [ -0.81% ]  Colgate Palm 2157.5  [ -0.32% ]  Dabur India 451.25  [ 1.05% ]  DLF 586.7  [ -0.24% ]  Dr. Reddy's Lab. 1307.1  [ -0.85% ]  GAIL (India) 161.1  [ 3.34% ]  Grasim Industries 3155.75  [ 0.04% ]  HCL Technologies 1163.75  [ -0.39% ]  HDFC Bank 766.4  [ 0.97% ]  Hero MotoCorp 4965.35  [ -0.10% ]  Hindustan Unilever 2202  [ 1.06% ]  Hindalco Industries 1109.6  [ 0.96% ]  ICICI Bank 1264.9  [ 1.77% ]  Indian Hotels Co. 650.45  [ -1.03% ]  IndusInd Bank 910.65  [ 1.22% ]  Infosys 1174.4  [ -0.61% ]  ITC 301.75  [ -2.03% ]  Jindal Steel 1209.85  [ 1.10% ]  Kotak Mahindra Bank 384.2  [ 0.91% ]  L&T 3926.85  [ -0.03% ]  Lupin 2279.5  [ -0.26% ]  Mahi. & Mahi 3082.15  [ -0.58% ]  Maruti Suzuki India 12987.45  [ -0.15% ]  MTNL 29.3  [ 1.49% ]  Nestle India 1423.25  [ 1.23% ]  NIIT 65.92  [ 1.54% ]  NMDC 87.88  [ -0.24% ]  NTPC 388.45  [ -0.13% ]  ONGC 290  [ -1.98% ]  Punj. NationlBak 102.6  [ 0.74% ]  Power Grid Corpn. 294.35  [ -1.75% ]  Reliance Industries 1354.6  [ 0.36% ]  SBI 949.1  [ -0.21% ]  Vedanta 330.05  [ 0.09% ]  Shipping Corpn. 316.4  [ -3.32% ]  Sun Pharmaceutical 1845.2  [ -2.43% ]  Tata Chemicals 749.75  [ -0.83% ]  Tata Consumer 1192.85  [ -0.15% ]  Tata Motors Passenge 363.4  [ 0.57% ]  Tata Steel 209.2  [ 0.31% ]  Tata Power Co. 408.8  [ -0.40% ]  Tata Consult. Serv. 2317.25  [ -0.45% ]  Tech Mahindra 1421.8  [ 0.12% ]  UltraTech Cement 11574.9  [ 0.82% ]  United Spirits 1283.45  [ 0.84% ]  Wipro 203.1  [ 1.65% ]  Zee Entertainment 82.18  [ -1.66% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

GANGA PHARMACEUTICALS LTD.

12 February 2026 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE615T01017 BSE Code / NSE Code 539680 / GANGAPHARM Book Value (Rs.) 14.02 Face Value 10.00
Bookclosure 25/09/2024 52Week High 15 EPS 0.17 P/E 70.18
Market Cap. 7.09 Cr. 52Week Low 9 P/BV / Div Yield (%) 0.86 / 0.00 Market Lot 8,000.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
The Company was originally incorporated in Mumbai as "Ganga Pharmaceuticals Private Limited" on 11th September, 1989 under the provisions of the Companies Act, 1956 vide certificate of incorporation issued by the Registrar of Companies, Mumbai. The Company was converted in to a Public Limited Company and consequently the name was changed to "Ganga Pharmaceuticals Private Limited" vide fresh certificate of incorporation dated 19th September, 1994 issued by the Registrar of Companies, Mumbai. The CIN No. of the Company is U99999MH1989PLC053392. The Company was set up by Late Shri Brijmohan Sharma, a qualified Ayurveda visionary in the year 1974 as a proprietary concern. In the year 1989, the proprietary firm was converted to a Private Limited Company and subsequently converted in to a Public Limited Company as on 19th September, 1994. The Company was established as a producer of quality Bulk Ayurvedic Medicines in Mumbai. Apart from manufacturing, the company is also into marketing, distribution of Bulk Ayurvedic Medicines. Under the Management of Late Shri Brijmohan Sharma, the Company had created an exceptional market reputation not only in Mumbai but all over Maharashtra. Initially, the company was manufacturing the following proprietary products: 1) Ampachan Vati; 2) Khadira Vati; 3) Nirmalaya churna Bearing in mind, the growing demand for the above products and newer products, increasing market share in Bulk Ayurvedic Medicine Sector and need for expertise in the business; Mr. Bharat Brijmohan Sharma, son of Late Shri Brijmohan Sharma took over the business. Being a Bachelor of Pharmacy from Pune University and a technocrat having rich experience in production and management of Ayurvedic unit, he not only extended the business to the neighbouring states but also introduced newer products within the company. As on date the company, it has 230 number of products in its total portfolio. We have been awarded a G.M.P Certification for following Good Manufacturing Practices under Revised Schedule T of Drugs & Cosmetics Rules, 1945 in respect of various categories of Tablets, Pills, Oils, Syrups and Powder based products by Food & Drug Administration, Maharashtra. Further, The company is characterized as Small Scale Industrial Unit by registering with the Directorate of Industries, Maharashtra. Key Events and Milestones: The following table sets forth the key events and milestones in the history of our Company, since incorporation: 1993 - Expanded the product portfolio to the current portfolio in 20 years 1993 - Obtained Import-Export License 2000 - Created and Developed Ayurvedic Pharmacopeias- a in-house guideline to be followed from manufacturing stage to packaging stage 2000 - Set up full fledge in-house Laboratory with the Manufacturing Unit 2001 - Received Good Manufacturing Practice (GMP) Certificate from FDA, Maharashtra 2004 - Established C & F depots in West Bengal & Orissa 2009 -`High Performance Capability and Moderate Financial Strength' Certificate received from NSICCRISIL